NeonMind Goes Public, Plans To Study Functional Mushrooms And Psilocybin As Treatments

Psychedelics biotech company NeonMind debuted on the Canadian Securities Exchange (CSE) Monday under the symbol ‘NEON.’

The listing comes after the company successfully closed its fully subscribed initial public offering on Dec. 30, for proceeds of about CA$4.6 million ($3.6 million).

“Our public listing is a significant milestone for us as we execute on our plan to grow our intellectual property portfolio and product development pipeline,” said NeonMind founder and CEO Penny White.

An Oversubscribed IPO: The Vancouver-based company became the first psychedelics company to go public this year, following the path of over two dozen companies in …

Full story available on Benzinga.com

More NeonMind Goes Public, Plans To Study Functional Mushrooms And Psilocybin As Treatments